Two title compounds, 4,4?diformyl-diphenoxyethane (compound 1, C16H14O4) and 4,4?4创-triformyl-triphenoxytriethylamine (compound 2, C27H27NO6), were synthesized by condensation of 4-hydroxybenzaldehyde with 1,2-dichlo...Two title compounds, 4,4?diformyl-diphenoxyethane (compound 1, C16H14O4) and 4,4?4创-triformyl-triphenoxytriethylamine (compound 2, C27H27NO6), were synthesized by condensation of 4-hydroxybenzaldehyde with 1,2-dichloroethane and tris(2-chloroethyl)amine, respectively in dimethyl formamide in the presence of anhydrous potassium carbonate. The crystal data are: monoclinic, P21/c, a = 7.571(2), b = 12.608(3), c = 7.357(2) ? b = 105.823(6)? V = 675.7(2) 3, Mr = 270.3, Z = 2, Dc = 1.328 g/cm3, F(000) = 284, m(MoKa) = 0.096 mm-1, R = 0.0537 and wR = 0.2189 for compound 1; and monoclinic, P21/n, a = 11.7162(6), b = 9.0042(6), c = 22.908(2) ? b = 99.505(1)? V = 2383.5(3) ?, Mr = 461.50, Z = 4, Dc = 1.286 g/cm3, F(000)= 976, m(MoKa) = 0.091 mm-1, R = 0.0464 and wR = 0.1462 for compound 2. The molecule of compound 1 (dialdehyde) is located at the crystallographic inversion center nearby the midpoint of C(8)C(8A) single bond. The three chains in the molecule of compound 2 (trialdehyde) are of non-crystallographic pseudo-C3 symmetry, and each of them is quite planar.展开更多
A series of aromatic acids has been tested as additives for the platinum-catalyzed hydrosilylation of styrene with triethoxysilane. Both excellent conversion of styrene and selectivity in favor of the ,β-adduct were ...A series of aromatic acids has been tested as additives for the platinum-catalyzed hydrosilylation of styrene with triethoxysilane. Both excellent conversion of styrene and selectivity in favor of the ,β-adduct were achieved using aminobenzoic acids as additive. Moreover, the use of 4-aminobenzoic acid led to significantly superior enhancement in both catalytic activity and selectivity among the tested aminobenzoic acids. Indeed, 100% conversion of styrene and 98.4% selectivity in favor of the β-adduct were obtained. Additionally, hydrosilylations of various alkenes with a variety of platinum catalysts have also been tested, and in each case the conversion of substrate and the selectivity of the β-adduct were promoted by using 4-aminobenzoic acid as additive.展开更多
The crystal structure of the title compound C16H18NO2+·C7H7SO3-·2H2O, (C23H29NSO7, Mr=463.53) has been determined by single-crystal X-ray diffraction analysis. The crystal belongs to the monoclinic system wi...The crystal structure of the title compound C16H18NO2+·C7H7SO3-·2H2O, (C23H29NSO7, Mr=463.53) has been determined by single-crystal X-ray diffraction analysis. The crystal belongs to the monoclinic system with space group P21/n, a=8.101(1), b=8.958(2), c=33.281(5)?,β= 94.910(1)(, V=2406.3(7)?3, Z=4, Dc=1.279g/cm3, μ=0.176mm-1, F(000)=984, final R=0.0409, and Rw=0.0860 for 4401 independent reflections. The result shows that in the crystal structure of the title compound the planar cations have two configurations with equal occupation ratio and are antiparally packed through π…π interactions. Similar packing energies in A and B are probably the main factor that leads to the disorder structure.展开更多
Hydroxy-phenyl)-5-(2-methyl-phenyl)-6-ethoxycarbonyl-cyclohexen-2-one has been synthesized and characterized by elemental analysis, IR, UV, H NMR and MS, and its crystal 1 structure was determined by X-ray single-crys...Hydroxy-phenyl)-5-(2-methyl-phenyl)-6-ethoxycarbonyl-cyclohexen-2-one has been synthesized and characterized by elemental analysis, IR, UV, H NMR and MS, and its crystal 1 structure was determined by X-ray single-crystal diffraction method. The crystal belongs to the monoclinic system, space group P21/c with a = 14.6298(13), b = 5.8623(5), c = 22.255(2) ?, β = 105.855(2)o, V = 1836.0(3) ?3, Mr = 350.40, Z = 4, Dc = 1.268 g/cm3, F(000) = 744, μ(MoKα) = 0.086 mm-1, R = 0.0680 and wR = 0.1498. The crystal analysis results show that the cyclohexene unit of the title compound has a quasi-chair conformation, and a centrosymmetric dimer with a 16-membered ring is produced by the intermolecular hydrogen bonds.展开更多
The title compound N-[1-(4-chlorophenyl)-1,4-dihydro-4-oxe-6-methylpyridazine- 3-carbonyl]-N(-benzoylhydrazine was prepared by the reaction of 1-(4-chlorophenyl)-1,4- dihydro-4-oxe-6-methylpyridazine-3-carboxylic acid...The title compound N-[1-(4-chlorophenyl)-1,4-dihydro-4-oxe-6-methylpyridazine- 3-carbonyl]-N(-benzoylhydrazine was prepared by the reaction of 1-(4-chlorophenyl)-1,4- dihydro-4-oxe-6-methylpyridazine-3-carboxylic acid with chloroformate ethyl ester and benzoyl hydrazine in the presence of triethylamine. The crystal structure ([C19H15ClN4O3]2·C2H5OH, Mr =811.67) has been determined by X-ray crystal structural analysis. The crystal is monoclinic, space group P21/c, with unit cell parameters a=13.296(3), b=17.155(3), c=17.459(3)?,β=98.959(4), Z=4, V=3934(1) ?3, Dc=1.371g/cm3, F(000)=1688, μ(MoKα)=0.226 mm-1, R=0.0495, wR=0.1348 for 3345 observed reflections (I >2σ(I)). The hydrogen bonds N(3)－H…O(1) , N(7)－H…O(4), and N(8)－H…O(2) can be observed.展开更多
The crystal structure of the title compound carvedilol, C24H25N2O4(Mr= 406. 47), has determined by single-crystal X-ray diffraction. The crystal is mono-clinic with space group P21/c, a=9. 094(l), b= l2. 754(1), c= 18...The crystal structure of the title compound carvedilol, C24H25N2O4(Mr= 406. 47), has determined by single-crystal X-ray diffraction. The crystal is mono-clinic with space group P21/c, a=9. 094(l), b= l2. 754(1), c= 18. 330(2) A, β=97. 36(1 )°, V= 2l08. 5(4) A 3, Z= 4, D.= l. 280 g/cm3, F(000) = 864, μ=O. O88mm-1 and final R= O. O368, wR(F2) = 0.0787 for reflections (I>2σ(I) ). X-ray anal-ysis reveals that the crystal is composed of a pair of enantiomer, and there are hydrogenbonds O(3) -H(3O) -N(l ) between the two enantimers. There are two planes in themolecule.展开更多
基金The authors thank the financial support of the Natural Science Foundation of Fujian Province (No. E0110010)
文摘Two title compounds, 4,4?diformyl-diphenoxyethane (compound 1, C16H14O4) and 4,4?4创-triformyl-triphenoxytriethylamine (compound 2, C27H27NO6), were synthesized by condensation of 4-hydroxybenzaldehyde with 1,2-dichloroethane and tris(2-chloroethyl)amine, respectively in dimethyl formamide in the presence of anhydrous potassium carbonate. The crystal data are: monoclinic, P21/c, a = 7.571(2), b = 12.608(3), c = 7.357(2) ? b = 105.823(6)? V = 675.7(2) 3, Mr = 270.3, Z = 2, Dc = 1.328 g/cm3, F(000) = 284, m(MoKa) = 0.096 mm-1, R = 0.0537 and wR = 0.2189 for compound 1; and monoclinic, P21/n, a = 11.7162(6), b = 9.0042(6), c = 22.908(2) ? b = 99.505(1)? V = 2383.5(3) ?, Mr = 461.50, Z = 4, Dc = 1.286 g/cm3, F(000)= 976, m(MoKa) = 0.091 mm-1, R = 0.0464 and wR = 0.1462 for compound 2. The molecule of compound 1 (dialdehyde) is located at the crystallographic inversion center nearby the midpoint of C(8)C(8A) single bond. The three chains in the molecule of compound 2 (trialdehyde) are of non-crystallographic pseudo-C3 symmetry, and each of them is quite planar.
基金Supported by the National High Technology Research and Development Program of China (2006AA03A134)Zhejiang Province Program (2008C14041)
文摘A series of aromatic acids has been tested as additives for the platinum-catalyzed hydrosilylation of styrene with triethoxysilane. Both excellent conversion of styrene and selectivity in favor of the ,β-adduct were achieved using aminobenzoic acids as additive. Moreover, the use of 4-aminobenzoic acid led to significantly superior enhancement in both catalytic activity and selectivity among the tested aminobenzoic acids. Indeed, 100% conversion of styrene and 98.4% selectivity in favor of the β-adduct were obtained. Additionally, hydrosilylations of various alkenes with a variety of platinum catalysts have also been tested, and in each case the conversion of substrate and the selectivity of the β-adduct were promoted by using 4-aminobenzoic acid as additive.
文摘The crystal structure of the title compound C16H18NO2+·C7H7SO3-·2H2O, (C23H29NSO7, Mr=463.53) has been determined by single-crystal X-ray diffraction analysis. The crystal belongs to the monoclinic system with space group P21/n, a=8.101(1), b=8.958(2), c=33.281(5)?,β= 94.910(1)(, V=2406.3(7)?3, Z=4, Dc=1.279g/cm3, μ=0.176mm-1, F(000)=984, final R=0.0409, and Rw=0.0860 for 4401 independent reflections. The result shows that in the crystal structure of the title compound the planar cations have two configurations with equal occupation ratio and are antiparally packed through π…π interactions. Similar packing energies in A and B are probably the main factor that leads to the disorder structure.
基金This work was financially supported by the Education Committee of Hunan Province (02C465)Hunan Provincial Key Discipline and Hunan Provincial General College Leader of Learning
文摘Hydroxy-phenyl)-5-(2-methyl-phenyl)-6-ethoxycarbonyl-cyclohexen-2-one has been synthesized and characterized by elemental analysis, IR, UV, H NMR and MS, and its crystal 1 structure was determined by X-ray single-crystal diffraction method. The crystal belongs to the monoclinic system, space group P21/c with a = 14.6298(13), b = 5.8623(5), c = 22.255(2) ?, β = 105.855(2)o, V = 1836.0(3) ?3, Mr = 350.40, Z = 4, Dc = 1.268 g/cm3, F(000) = 744, μ(MoKα) = 0.086 mm-1, R = 0.0680 and wR = 0.1498. The crystal analysis results show that the cyclohexene unit of the title compound has a quasi-chair conformation, and a centrosymmetric dimer with a 16-membered ring is produced by the intermolecular hydrogen bonds.
基金the National Nature Science Foundation (29832050).
文摘The title compound N-[1-(4-chlorophenyl)-1,4-dihydro-4-oxe-6-methylpyridazine- 3-carbonyl]-N(-benzoylhydrazine was prepared by the reaction of 1-(4-chlorophenyl)-1,4- dihydro-4-oxe-6-methylpyridazine-3-carboxylic acid with chloroformate ethyl ester and benzoyl hydrazine in the presence of triethylamine. The crystal structure ([C19H15ClN4O3]2·C2H5OH, Mr =811.67) has been determined by X-ray crystal structural analysis. The crystal is monoclinic, space group P21/c, with unit cell parameters a=13.296(3), b=17.155(3), c=17.459(3)?,β=98.959(4), Z=4, V=3934(1) ?3, Dc=1.371g/cm3, F(000)=1688, μ(MoKα)=0.226 mm-1, R=0.0495, wR=0.1348 for 3345 observed reflections (I >2σ(I)). The hydrogen bonds N(3)－H…O(1) , N(7)－H…O(4), and N(8)－H…O(2) can be observed.
文摘The crystal structure of the title compound carvedilol, C24H25N2O4(Mr= 406. 47), has determined by single-crystal X-ray diffraction. The crystal is mono-clinic with space group P21/c, a=9. 094(l), b= l2. 754(1), c= 18. 330(2) A, β=97. 36(1 )°, V= 2l08. 5(4) A 3, Z= 4, D.= l. 280 g/cm3, F(000) = 864, μ=O. O88mm-1 and final R= O. O368, wR(F2) = 0.0787 for reflections (I>2σ(I) ). X-ray anal-ysis reveals that the crystal is composed of a pair of enantiomer, and there are hydrogenbonds O(3) -H(3O) -N(l ) between the two enantimers. There are two planes in themolecule.
